☰

Robin Bogner - Publications

Affiliations: 
University of Connecticut, Storrs, CT, United States 
Area:
Pharmaceutical Chemistry, Pharmacology
Tree Info Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Sane P, Bogner RH, Bhatnagar B, Tchessalov S. Reconstitution of Highly-Concentrated Lyophilized Proteins: Part 1 Amorphous Formulations. Journal of Pharmaceutical Sciences. PMID 32070705 DOI: 10.1016/J.Xphs.2020.02.006  0.71
2018 Fan TH, Li JQ, Minatovicz B, Soha E, Sun L, Patel S, Chaudhuri B, Bogner R. Phase-Field Modeling of Freeze Concentration of Protein Solutions. Polymers. 11. PMID 30959994 DOI: 10.3390/Polym11010010  0.372
2017 Kleppe MS, Haskell RJ, Bogner RH. Biorelevant Media Slows the Solution-Mediated Phase Transformation of Amorphous Spironolactone. Journal of Pharmaceutical Sciences. PMID 29122582 DOI: 10.1016/j.xphs.2017.10.041  0.307
2015 Grobelny P, Kazakevich I, Zhang D, Bogner R. Amorphization of itraconazole by inorganic pharmaceutical excipients: comparison of excipients and processing methods. Pharmaceutical Development and Technology. 20: 118-27. PMID 25312240 DOI: 10.3109/10837450.2014.959181  0.394
2012 Qian KK, Wurster DE, Bogner RH. Spontaneous crystalline-to-amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 3: effect of moisture. Pharmaceutical Research. 29: 2698-709. PMID 22430066 DOI: 10.1007/S11095-012-0734-4  0.747
2012 Greco K, Bogner R. Solution-mediated phase transformation: significance during dissolution and implications for bioavailability. Journal of Pharmaceutical Sciences. 101: 2996-3018. PMID 22213419 DOI: 10.1002/Jps.23025  0.751
2012 Qian KK, Bogner RH. Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems. Journal of Pharmaceutical Sciences. 101: 444-63. PMID 21976048 DOI: 10.1002/Jps.22779  0.733
2011 Greco K, Bogner R. Solution-mediated phase transformation of haloperidol mesylate in the presence of sodium lauryl sulfate. Aaps Pharmscitech. 12: 909-16. PMID 21732157 DOI: 10.1208/S12249-011-9656-4  0.75
2011 Qian KK, Suib SL, Bogner RH. Spontaneous crystalline-to-amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 2: amorphization capacity and mechanisms of interaction. Journal of Pharmaceutical Sciences. 100: 4674-86. PMID 21656521 DOI: 10.1002/Jps.22657  0.745
2011 Qian KK, Bogner RH. Spontaneous crystalline-to-amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 1: thermodynamics of spontaneous amorphization. Journal of Pharmaceutical Sciences. 100: 2801-15. PMID 21337545 DOI: 10.1002/Jps.22519  0.756
2011 Greco K, Mcnamara DP, Bogner R. Solution-mediated phase transformation of salts during dissolution: investigation using haloperidol as a model drug. Journal of Pharmaceutical Sciences. 100: 2755-68. PMID 21328581 DOI: 10.1002/Jps.22507  0.765
2011 Qian KK, Bogner RH. Differential heat of adsorption of water vapor on silicified microcrystalline cellulose (SMCC): an investigation using isothermal microcalorimetry. Pharmaceutical Development and Technology. 16: 616-26. PMID 20722499 DOI: 10.3109/10837450.2010.508073  0.714
2011 Greco K, Bergman TL, Bogner R. Design and characterization of a laminar flow-through dissolution apparatus: Comparison of hydrodynamic conditions to those of common dissolution techniques. Pharmaceutical Development and Technology. 16: 75-87. PMID 20105086 DOI: 10.3109/10837450903499341  0.722
2010 Greco K, Bogner R. Crystallization of amorphous indomethacin during dissolution: effect of processing and annealing. Molecular Pharmaceutics. 7: 1406-18. PMID 20459092 DOI: 10.1021/Mp1000197  0.748
2010 Bose S, Bogner RH. Solventless visible light-curable coating: II. Drug release, mechanical strength and photostability. International Journal of Pharmaceutics. 393: 41-7. PMID 20371275 DOI: 10.1016/J.Ijpharm.2010.03.052  0.546
2010 Bose S, Bogner RH. Solventless visible light-curable coating: I. Critical formulation and processing parameters. International Journal of Pharmaceutics. 393: 32-40. PMID 20138131 DOI: 10.1016/J.Ijpharm.2010.01.041  0.549
2008 Bhatnagar BS, Pikal MJ, Bogner RH. Study of the individual contributions of ice formation and freeze-concentration on isothermal stability of lactate dehydrogenase during freezing. Journal of Pharmaceutical Sciences. 97: 798-814. PMID 17506511 DOI: 10.1002/Jps.21017  0.716
2007 Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. Pharmaceutical Development and Technology. 12: 505-23. PMID 17963151 DOI: 10.1080/10837450701481157  0.706
2007 Bose S, Bogner RH. Solventless photocurable film coating: evaluation of drug release, mechanical strength, and photostability. Aaps Pharmscitech. 8: E57. PMID 17915807 DOI: 10.1208/Pt0803057  0.551
2007 Bose S, Bogner RH. Solventless pharmaceutical coating processes: a review. Pharmaceutical Development and Technology. 12: 115-31. PMID 17510883 DOI: 10.1080/10837450701212479  0.546
2006 Bose S, Kelly B, Bogner RH. Design space for a solventless photocurable pharmaceutical coating Journal of Pharmaceutical Innovation. 1: 44-53. DOI: 10.1007/Bf02784880  0.534
2005 Bhatnagar BS, Nehm SJ, Pikal MJ, Bogner RH. Post-thaw aging affects activity of lactate dehydrogenase. Journal of Pharmaceutical Sciences. 94: 1382-8. PMID 15858849 DOI: 10.1002/Jps.20345  0.689
2005 Bhatnagar BS, Cardon S, Pikal MJ, Bogner RH. Reliable determination of freeze-concentration using DSC Thermochimica Acta. 425: 149-163. DOI: 10.1016/J.Tca.2004.06.017  0.698
Show low-probability matches.